Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Published on by Academic Awards

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. πŸ¦ πŸ”¬πŸ“š

Publication Profile

Scopus

Orcid

πŸŽ“ Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. πŸ§¬πŸ”¬πŸ“–

πŸ… Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. πŸ§ͺπŸ”¬πŸ“š

πŸ”¬ Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance πŸ’Š, and host-pathogen interactions πŸ₯. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. πŸŒπŸ”

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan πŸ¦ πŸ’Š (Heliyon, 2025)Β 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025)Β 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🀰🦠 (Pathogens, 2025)Β 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases πŸ’ŠπŸ¦  (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠πŸ§ͺ (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan πŸ’ŠπŸ¦  (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024)Β 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review πŸ¦ πŸ“– (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(Ξ±K) in mild-to-moderate COVID-19 patients πŸ’‰πŸ¦  (Human Vaccines and Immunotherapeutics, 2024)Β 
πŸ”Ÿ Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives πŸ¦ πŸ’‰ (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

Nithyadevi Duraisamy | Virology | Best Researcher Award

Published on by Academic Awards

Dr. Nithyadevi Duraisamy | Virology | Best Researcher Award

Research Scientist, Long Island University, United States

Dr. Nithyadevi Duraisamy is a dedicated nano-biomedical scientist with expertise in nanomaterial synthesis, drug delivery systems, and analytical instrumentation. She has over five years of experience in developing novel biopolymer-based drug formulations for targeted therapy. Currently a Postdoctoral Research Fellow at Long Island University, Brooklyn, NY, she is working on orthopedic knee implantation and drug-molecule interactions. Her previous roles include research fellowships at UCONN Health Center and an Assistant Professor at Erode Builders Educational Trusts, India. Dr. Duraisamy holds a Ph.D. in Interdisciplinary Physics-Material Science from Bharathiar University, India. Her work spans nanotechnology, photocatalysis, biomedical applications, and water purification. She has received the UGC Fellowship for Meritorious Students (2013) and the Best Faculty Award (2016).

Publication Profile

Google Scholar

πŸ”¬ Professional Experience

Dr. Nithyadevi Duraisamy is a Postdoctoral Research Fellow at Long Island University, leading projects on orthopedic knee implantation using electrospinning and 3D printing. She collaborates on drug interaction studies with Dassault Systems’ Living Heart Model. As a Research Fellow at UCONN Health, she contributed to NIH-funded studies on ionically conducting biopolymers for tissue regeneration. Previously, she was an Assistant Professor and Doctoral Researcher at Bharathiar University, specializing in biopolymer-induced nanoparticles for targeted breast cancer therapy. Her expertise spans photocatalysis, biomaterials, and regenerative medicine, driving advancements in nanomedicine and drug delivery. βš›οΈπŸ’ŠπŸ¦Ύ

πŸŽ“ Academic Background

Dr. Nithyadevi Duraisamy holds a Ph.D. in Interdisciplinary Physics-Material Science (2015) from Bharathiar University, focusing on biopolymer-induced nanoparticles for cancer therapy. She earned an M.Phil. in Physics (2010) and a PG Diploma in Nanoscience and Technology (2010) from the same university. Her academic journey began with an M.Sc. in Physics (2009) from PSG College of Arts and Science and a B.Sc. in Physics (2007) from Vellalar College for Women. Her education has equipped her with expertise in nanomaterials, biomaterials, and advanced analytical techniques for biomedical applications. βš›οΈπŸ“šπŸ”¬

πŸ† Honors & Awards

Dr. Nithyadevi Duraisamy has been recognized for her academic excellence and contributions to research. In 2016, she received the Best Faculty Award for her dedication to teaching and mentoring students. She was also awarded the prestigious University Grants Commission (UGC) Fellowship for Meritorious Students in 2013 by UGC, India, for her outstanding research in nanoscience and material science. These accolades highlight her commitment to innovation, education, and scientific advancements in interdisciplinary physics and biomedical applications. πŸŒŸπŸŽ–οΈπŸ”¬

πŸ”¬ Research Focus

Dr. Nithyadevi Duraisamy’s research spans biomedical materials, nanotechnology, and electrochemical sensing. Her work in bioactive polymers and electrical stimulation strategies contributes to musculoskeletal tissue regeneration 🦴. She has developed electrochemical platforms for detecting dopamine 🧠 and pesticides 🌿 using advanced nanocomposites. Her expertise includes functional biomaterials for spinal repair, metal/metal oxide nanoparticles for antimicrobial applications 🦠, and photocatalytic materials for environmental remediation 🌍. Recently, she has explored machine learning in virology πŸ¦ πŸ’» and graphitic carbon nitride for electrocatalysis ⚑. Her interdisciplinary approach integrates material science, biotechnology, and engineering for healthcare and environmental applications. πŸš€

Publication Top Notes

  • 🦴 Bioactive polymeric materials & electrical stimulation for musculoskeletal repair – 152 citations, 2020
  • 🧠 Electrochemical platform using Yβ‚‚O₃/BN for dopamine detection – 88 citations, 2021
  • 🌿 ZrP/GO-based nanoarchitecture for fenitrothion detection – 61 citations, 2021
  • 🦴 Functional biomaterials for intervertebral disc regeneration – 53 citations, 2020
  • ⚑ TiOβ‚‚-SnOβ‚‚ composite nanoparticles for photocatalysis – 19 citations, 2013
  • 🦠 Ag/TiOβ‚‚ core-shell nanoparticles for biological applications – 18 citations, 2017
  • 🦠 Bio-surfactant induced Ag–TiOβ‚‚ core-shell nanoparticles for microbial inhibition – 15 citations, 2015
  • 🧬 Protein synthesis & characterization – 6 citations, 2020
  • πŸ¦ πŸ’» Machine learning for BCoV epitope mapping – Published 2024
  • ⚑ Graphitic carbon nitride for electrocatalysis – Published 2022
  • πŸ”© Composition & optical microstructure of gray cast iron – Published 2013